Techcyte
Founded Year
2013Stage
Series C | AliveTotal Raised
$34.62MLast Raised
$8.4M | 10 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+33 points in the past 30 days
About Techcyte
Techcyte focuses on aiding in the practice of pathology with its artificial intelligence (AI) software platform in the clinical pathology sector. It offers a range of AI-assisted diagnostic tools that improve the efficiency and accuracy of laboratory testing. Techcyte's solutions cater to various applications including oncology, microbiology, hematology, and infectious disease, as well as industries such as veterinary, environmental, and human healthcare. It was founded in 2013 and is based in Orem, Utah.
Loading...
ESPs containing Techcyte
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The digital pathology — oncology diagnostics market digitizes and obtains high-resolution images of cancerous tissue samples. These digital images can be easily stored, shared, and accessed remotely by pathologists, enabling more efficient collaboration and second opinions. The market includes various hardware and software solutions for scanning, storing, analyzing, and managing digital pathology …
Techcyte named as Highflier among 15 other companies, including Proscia, Ibex, and Paige.
Loading...
Research containing Techcyte
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Techcyte in 3 CB Insights research briefs, most recently on Jul 15, 2024.
Aug 10, 2023
The oncology tech market map
Expert Collections containing Techcyte
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Techcyte is included in 3 Expert Collections, including Digital Health.
Digital Health
11,082 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
456 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Artificial Intelligence
6,855 items
Techcyte Patents
Techcyte has filed 10 patents.
The 3 most popular patent topics include:
- hematology
- immunologic tests
- microscopy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/17/2020 | 5/28/2024 | Microscopy, Microscopes, Lens mounts, Cell imaging, Staining | Grant |
Application Date | 1/17/2020 |
|---|---|
Grant Date | 5/28/2024 |
Title | |
Related Topics | Microscopy, Microscopes, Lens mounts, Cell imaging, Staining |
Status | Grant |
Latest Techcyte News
Sep 6, 2024
News Provided By Share This Article OREM, UT, UNITED STATES, September 6, 2024 / EINPresswire.com / -- Sporecyte , the leading innovator in mold testing, is pleased to announce the release of the AirTrapXL cassette, manufactured by its trusted partner, Apacor. This new product represents a groundbreaking advancement in the sampling of airborne mold and particulates. The new cassette is less expensive, easier to use, and is made from plastic that can be recycled. The AirTrapXL cassette’s innovative design eliminates common problems associated with traditional cassettes, such as lost stickers and separate caps. The cassette features hinged caps for both the inlet and outlet, ensuring secure closure while simplifying the sample collection process. It also includes a barcode which can be used with Sporecyte’s digital chain of custody web app. "We are extremely excited to bring the AirTrapXL to market as part of our Sporecyte mold testing service," said Jason Callahan, General Manager at Sporecyte. "The collaboration with Apacor created a revolutionary product that sets a new standard for convenience and reliability in mold testing." AirTrap XL cassettes are compatible with most industry standard air sampling pumps. The construction uses 46% less plastic than comparable cassettes and was designed to reduce breakage when shipping to the lab. Sporecyte and Apacor's partnership highlights our shared values of innovation, customer satisfaction and care for the environment. The AirTrapXL can now be ordered at shop.sporecyte.com for $4.50 per cassette. About Sporecyte: Sporecyte developed the world’s first AI-powered mold and air particulate report. Our lab and AI-based technology focuses on providing home inspectors and industry professionals access to fast, accurate, and affordable mold and air quality testing. About Techcyte: Founded in 2013 in Orem, Utah, Techcyte is a world leader in AI-based digital diagnostics, including clinical and anatomic pathology. Techcyte’s AI and workflow platform uses AI to perform analysis of whole slide images, transforming diagnostics for human, animal, and environmental labs around the world. Visit techcyte.com for more information. Techcyte’s clinical pathology platform is for Research Use Only in the United States. Troy Bankhead
Techcyte Frequently Asked Questions (FAQ)
When was Techcyte founded?
Techcyte was founded in 2013.
Where is Techcyte's headquarters?
Techcyte's headquarters is located at 1106 North 1200 West, Orem.
What is Techcyte's latest funding round?
Techcyte's latest funding round is Series C.
How much did Techcyte raise?
Techcyte raised a total of $34.62M.
Who are the investors of Techcyte?
Investors of Techcyte include Alta Ventures Mexico, Zoetis, ARUP Laboratories, Paycheck Protection Program, University of Utah and 3 more.
Loading...
Loading...